Latest Articles
With this unprecedented $5-million gift, one family hopes to bring overdue attention to endometriosis care in Canada - Sinai Health
With this unprecedented $5-million gift, one family hopes to bring overdue attention to endometriosis care in Canada Sinai Health
Published: Oct. 29, 2025, noon
Ultrastructural evaluation of lithium-induced autophagic and mitochondrial stress in 3D endometrial and neuroblastoma spheroids - Nature
Ultrastructural evaluation of lithium-induced autophagic and mitochondrial stress in 3D endometrial and neuroblastoma spheroids Nature
Published: Oct. 28, 2025, 3:42 p.m.
Enhanced analysis of endometriosis patients’ plasma using #Enzian annotation highlights potential biomarkers for early-stages of disease - Nature
Enhanced analysis of endometriosis patients’ plasma using #Enzian annotation highlights potential biomarkers for early-stages of disease Nature
Published: Oct. 28, 2025, 9:29 a.m.
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment - TipRanks
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment TipRanks
Published: Oct. 27, 2025, 5:04 p.m.
Mechanism of action of HuPoSan on EMs rats as revealed by multi-omics combined with network pharmacology - ScienceDirect.com
Mechanism of action of HuPoSan on EMs rats as revealed by multi-omics combined with network pharmacology ScienceDirect.com
Published: Oct. 27, 2025, 6 a.m.
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors - The Manila Times
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors The Manila Times
Published: Oct. 24, 2025, 3:57 p.m.
KEYTRUDA + LENVIMA shows durable 5-year survival benefit in advanced endometrial cancer - Indian Pharma Post
KEYTRUDA + LENVIMA shows durable 5-year survival benefit in advanced endometrial cancer Indian Pharma Post
Published: Oct. 22, 2025, 5:03 p.m.
Cedars-Sinai Expert Discusses Endometriosis and Fibroids - Cedars-Sinai
Cedars-Sinai Expert Discusses Endometriosis and Fibroids Cedars-Sinai
Published: Oct. 22, 2025, 4 p.m.
‘It’s not just cramps’: Women forced to seek endometriosis treatment privately amid long NHS waiting times - Suffolk News
‘It’s not just cramps’: Women forced to seek endometriosis treatment privately amid long NHS waiting times Suffolk News
Published: Oct. 22, 2025, 4 a.m.
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer - Pharmacy Times
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer Pharmacy Times
Published: Oct. 21, 2025, 3:34 a.m.
Link copied to clipboard!